Nebenwirkungen · BeneFIX
BeneFIX 250 IU powder and solvent for solution for injection BeneFIX 500 IU powder and solvent for solution for injection BeneFIX 1000 IU powder and solvent for solution for injection BeneFIX 1500 IU powder and solvent for solution for injection BeneFIX 2000 IU powder and solvent for solution for injection BeneFIX 3000 IU powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 9
HOS-086898 · Präparat HOS-083385
Inhibitor development A clinically relevant, low responding inhibitor was detected in 1 out of 65 BeneFIX patients (including 9 patients participating only in the surgery study) who had previously received plasma- derived products. This patient was able to continue treatment with BeneFIX with no anamnestic rise in inhibitor or anaphylaxis (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-03-07T10:33:00Z · SHA-256 32f21758f2a70ebcdb4270dc878969f45b1067fad6cafd8c9319175576981935 · Passage a1818cc3c8076c6a5904a4924aa1e8ea568582f414e2fed64157a4508c194fb4 · Zeichen 6195–6554 im Abschnitt